250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical VC (Venture Capital) Funds in Australia in April 2025

A list of 50 VC (Venture Capital) funds that invest in Medical startups based in Australia. We rank investors based on the number of investments they made in Medical companies from Australia. We update this investor list every month.

Top 50 Medical VC (Venture Capital) Funds in Australia in April 2025

Investor Medical Australia investments
Brandon Capital 11
Artesian VC 8
Medical Research Commercialisation Fund (MRCF) 7
Uniseed 6
Uniseed Ventures 5
Main Sequence Ventures 4
Stoic VC 4
Right Click Capital 3
Transition Level Investments 3
Giant Leap Fund 3
Sydney Angels 2
Regal Funds Management 2
Clinton Capital Partners 2
Carthona Capital 2
Starfish Ventures 2
Folklore Ventures 2
Jolimont Global Mining Systems 2
Fund WA 2
Blackbird Ventures 2
Purpose Ventures 2
EVP 2
Horizons Ventures 2
Australian Medical Angels 2
CVC Capital Partners 1
HESTA 1
Hostplus 1
Square Peg Capital 1
HTC 1
AngelLoop 1
Medibank 1
CP Ventures 1
Thorney Investment 1
BetterLabs Ventures 1
SFC Capital 1
Lilly Ventures 1
SG Hiscock 1
CSIRO 1
VU Venture Partners 1
Jelix Ventures 1
Tyson & Blake 1
Pollenizer 1
Black Nova Venture Capital 1
Ramsay Health Care 1
Queensland Investment Corporation 1
Breakthrough Victoria 1
Skip Capital 1
SOSV 1
QIC BioVentures 1
Northpond Ventures 1
Watermark Funds Management 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Brandon Capital VC Fund · Melbourne, Victoria, Australia · 5 investments in the past 12 months
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • AdvanCell — AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.
  • Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
Artesian VC VC Fund · Melbourne, Victoria, Australia · 5 investments in the past 12 months
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Hong Kong
Portfolio highlights
  • GALY — Saving Our Planet by Transitioning the World to Cellular Agriculture
  • Ohmie Go — EV charging solutions, shared electric vehicles, shared e-bikes & e-scooters delivered to residents as a premium managed service and amenity - An intelligent way to get EV ready with one seamless experience.
  • Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Medical Research Commercialisation Fund (MRCF) VC Fund · Melbourne, Victoria, Australia
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Uniseed VC Fund · Brisbane, Queensland, Australia · 3 investments in the past 12 months
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Diraq — Diraq uses spins in silicon quantum dots as qubits. Diraq's qubits are compatible with existing CMOS processes and can fit billions of qubits on a single chip. To transform our world, quantum computers need billions of qubits and Diraq has the IP, the team and the plan to get there.
  • Celosia Therapeutics — The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.
  • Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Uniseed Ventures VC Fund · Brisbane, Queensland, Australia
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Main Sequence Ventures VC Fund · Sydney, New South Wales, Australia · 10 investments in the past 12 months
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Series B
  • Australia, United States, Philippines
Portfolio highlights
  • Myriota — Myriota delivers cutting-edge IoT technology through low-cost, low-power satellite connectivity for global remote monitoring.
  • ElectraLith — ElectraLith develops direct lithium extraction and refining technology designed for efficient and sustainable lithium production.
  • Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
Stoic VC VC Fund · Sydney, New South Wales, Australia
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Funding Round, Series A
  • Australia, United States, United Kingdom
Portfolio highlights
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
  • Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
  • Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Right Click Capital VC Fund · Sydney, New South Wales, Australia
Right Click Capital - Australian Venture Capital Firm
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Seed, Series A, Funding Round
  • Australia, Singapore, United States
Portfolio highlights
  • black.ai — Build smarter spaces with Black.ai
  • Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
  • Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
Transition Level Investments VC Fund · Brisbane, Queensland, Australia
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more
Investment focus
  • SaaS, Artificial Intelligence, Software
  • Seed, Pre-Seed, Series A
  • Australia, United States
Portfolio highlights
  • Kapiche — Top-rated customer feedback analytics platform. Instant insights. No setup or coding. Kapiche ingests & analyzes feedback in minutes for real customer insights.
  • FloodMapp — Enhance operational efficiency, lead time, situational awareness and decision making using FloodMapp rapid flood mapping software.
  • Chipper Cash — Join over 5 million people securely sending and receiving money with Chipper Cash. Great app to send and receive money across a number of countries, highly recommended as a money transfer alternative.
Giant Leap Fund VC Fund · Melbourne, Victoria, Australia
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more
Investment focus
  • Health Care, Information Technology, SaaS
  • Seed, Series A, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • Modo — Declutter your mind with our app to boost your mental wellbeing and productivity. modo helps you be present in the moment and focus on what matters most.
  • Mindset Health — Mindset Health is a digital therapeutics company that helps people manage chronic health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy.
  • More Good Days — More Good Days offers evidence-based pain management programes, education, and health services.
Sydney Angels VC Fund · Sydney, New South Wales, Australia
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
  • Software, Health Care, SaaS
  • Seed, Angel, Series A
  • Australia, United States
Portfolio highlights
  • Okkular — Okkular is an AI based fashion tech startup.
  • Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
  • Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Regal Funds Management VC Fund · Sydney, New South Wales, Australia
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Funding Round, Series B, Convertible Note
  • Australia, United States, United Kingdom
Portfolio highlights
  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
  • Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
  • Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
Clinton Capital Partners VC Fund · Sydney, New South Wales, Australia
Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.
Show more
Investment focus
  • Software, E-Commerce, Health Care
  • Seed, Series A, Funding Round
  • Australia, United States
Portfolio highlights
  • OpusXenta — Byond is comprehensive business management software for cemeteries & crematoria, streamlining operations with mapping, record-keeping, sales management and more.
  • PaidRight — Know your payroll compliance. Monitor variances in your payroll, get insights and visibility into your own payroll systems and processes so your employees are paid right.
  • FLK It Over — Sign documents online easily with FLK it over. Get started with our electronic signature software in just 2 minutes with our 14-day free trial. Try it now!
Carthona Capital VC Fund · Sydney, New South Wales, Australia · 8 investments in the past 12 months
Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Seed, Series A, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Safewill — Safewill is Australia's leading online Will writing platform. With thousands of users, Safewill makes it easy and affordable to write your own legally binding will
  • BuildPass — Unlock the full potential of your site with easy-to-use AI software to streamline operations, reduce admin tasks, and ensure every project is on track and compliant.
  • Ajust — Ajust makes it easy to resolve customer complaints with banks, telcos and energy companies. It's fast, fair and free for consumers.
Starfish Ventures VC Fund · Melbourne, Victoria, Australia
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
  • Software, Enterprise Software, Information Technology
  • Series A, Series B, Funding Round
  • United States, Australia, Philippines
Portfolio highlights
  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,274,002 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Folklore Ventures VC Fund · Sydney, New South Wales, Australia
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more
Investment focus
  • Software, Apps, Information Technology
  • Seed, Series A, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Kry10 — Kry10 is a safe operating system for SDMs.It makes the transition to an intelligent, cloud-connected, and adaptively driven future possible for automobiles, electricity grids, satellites, and medical equipment.
  • SimConverse — SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty.
  • Forever Network — Forever Network is a social-first sports media company. Our keystone brand, Basketball Forever, is the worlds largest independent sports media channel.
Jolimont Global Mining Systems VC Fund · Denver, Colorado, United States
Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.
Show more
Investment focus
  • Construction, Software, SaaS
  • Funding Round, Seed, Convertible Note
  • Australia, United States
Portfolio highlights
  • SciAps — SciAps specializes in portable analytical instruments with the power to measure any element. Our industry-leading X-ray fluorescence (XRF) and laser-based (LIBS) analyzers are at work across every major industry.
  • APE Mobile — APE Mobile develops a paperless site application for contractors in Australia. Its site application comprises features, such as operational forms, safety forms, project management, actions and defects, drawings and documents, and redline markup. David Hayward and Matthew Edwards founded APE Mobile in January 2, 2009. Its headquarters is inLeederville in Australia.
  • QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Fund WA VC Fund · Perth, Western Australia, Australia
FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Seed, Series A
  • Australia
Portfolio highlights
  • Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
  • VitalTrace — VitalTrace is a medical device company helps mothers and children during labour and delivery by innovating new monitoring devices.
Blackbird Ventures VC Fund · Sydney, New South Wales, Australia · 21 investments in the past 12 months
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Seed, Series A, Pre-Seed
  • Australia, United States, New Zealand
Portfolio highlights
  • Heidi Health — Heidi Health is modernizing primary care with AI-powered technologies to improve care's quality and accessibility. its creators and engineers is to completely eradicate missed and sluggish diagnoses worldwide. They are committed to bridging the gap between the level of care that patients desire and the level of care that doctors can delivergiven their budget constraints. To create a platform where patients can quickly and easily get the treatment they require and to give every clinician the resources they need to deliver care that is secure, efficient,
  • Sonder — One app. One go-to. One support system.Sonder is the trusted wellbeing partner for some of the world’s most innovative organisations as they reimagine how to care and support their people.With a clear purpose of breaking down barriers to help, providing the right support to people at the right time. Acknowledging that there are often multiplefactors at play, and wellbeing comprises of cultural, social, environmental and vocational factors, all which play a part in getting to the root cause of issues, and on a path to wellness.The heart of Sonder's solution is a technology-driven platform supported in real time by medical and mental health experts - experts that are available every minute of every day. Their mission is to get the right outcome across any wellbeing or safety issue.Trusted by major corporations, education providers and Government to enhance wellbeing across the world, Sonder is on a mission to create a better world, accepting differences and supportive of others. A world where it's OK to ask for help, for anything, at any time of the day or night.It takes humans to help other humans. That’s why Sonder combines a human first, tech supported approach.
  • Instant — The world's best-performing online checkout that maximises revenue for your brand!
Purpose Ventures VC Fund · Perth, Western Australia, Australia · 3 investments in the past 12 months
Purpose Ventures is a Venture Capital Fund in Perth Western Australia backing the next generation of entrepreneurs and innovators.
Show more
Investment focus
  • EdTech, Medical, Education
  • Seed
  • Australia
Portfolio highlights
  • PlanCare — Plan Care is a technology platform that helps participants via dedicated plan managers by providing guidance and responding to queries.
  • My Mirror — Find the right online psychologist in Australia, tailored to your needs and schedule. Start online therapy today with no wait times. Book now, pay later
  • Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
EVP VC Fund · Sydney, New South Wales, Australia · 2 investments in the past 12 months
EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Series A, Seed, Funding Round
  • Australia, New Zealand, United States
Portfolio highlights
  • splose — splose isn’t just practice management software. It's your ally in handling the ins-and-outs of running a practice and a savvy tool for growth. At splose, we are dedicated to continuously improving and embracing the power of AI and automation to give healthcare professionals like you more time to focus on what matters most.
  • Nexl — Nexl believes that CRM systems should be easy-to-use, affordable, and fully automated. They made it their mission to enable law firm's around the world to take back control over their business development efforts and enable them to grow at their full potential.
  • InvestorHub — We provide comprehensive access to listed capital raises for institutional, family office and high net worth investors.
Horizons Ventures VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 8 investments in the past 12 months
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
  • Biotechnology, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • Notpla — We are a combination of designers and chemists, engineers and entrepreneurs. We’re hard to define because what we’re doing hasn’t been done before. We create advanced packaging solutions that disappear, naturally.
  • Owlstone Medical — Owlstone Medical has developed a breathalyzer for disease. With a focus on non-invasive diagnostics for cancer, inflammatory disease, and infectious disease, the company aims to save 100,000 lives and $1.5B in healthcare costs.The company’s Breath Biopsy® platform has introduced a new diagnostic modality making it possible to discover novelnon-invasive biomarkers in breath using a platform with the potential to transition to point-of-care. The award-winning ReCIVA Breath Sampler ensures a reliable collection of breath samples. The volatile organic compounds (VOCs) present in the breath are analyzed using proven microchip chemical sensor technology (FAIMS) to detect biomarkers of disease.The Breath Biopsy platform can be used in clinical diagnostics and precision medicine with applications in cancer and a wide range of other medical conditions. Highly sensitive and selective, these tests allow for early diagnosis when treatments are more effective and more lives can be saved.Owlstone Medical is currently developing tests for lung and colorectal cancer, two of the most common cancer killers worldwide, and for asthma stratification by the therapeutic response. The company also Breath Biopsy products and services to academic, clinical, and pharma partners who want to develop breath-based diagnostics for their own applications.
  • Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Australian Medical Angels VC Fund
Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia.
Show more
Investment focus
  • Events, Sports, Cycling
  • Pre-Seed
  • Hong Kong
Portfolio highlights
  • Sineva — Sineva is a medical device manufacturing firm that makes ultrasonography simulators.
  • VueMotion Labs — Optimize athletic performance with VueMotion's AI-driven movement analysis. Accessible, affordable, and trusted by pro teams worldwide. Start testing today!
  • Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
CVC Capital Partners VC Fund · Luxembourg, Luxembourg, Luxembourg · 2 investments in the past 12 months
CVC has seven complementary strategies across private equity, secondaries and credit, through which we invest on behalf of pension funds and other leading institutions
Show more
Investment focus
  • Software, Financial Services, Retail
  • Private Equity, Post-IPO Equity, Funding Round
  • United States, United Kingdom, Indonesia
Portfolio highlights
  • Odevo — We are on a mission to become the leading force within property management and residential services through the combined power of people and technology. Join us.
  • Hempel — We help you protect your most valuable assets with our high-quality coatings
  • Sunday Natural — Sunday Natural develops various kinds of organic, plant-based, and healthy products. It offers vitamins, supplements, fruits, vegetables, tea, skincare items and cosmetics that are made with scientific and clinical research. Sunday Natural is based in Berlin, Germany.
HESTA VC Fund · Melbourne, Victoria, Australia · 2 investments in the past 12 months
HESTA Super Fund is the Australian industry superannuation fund for people working in health and community services. Become a member today.
Show more
Investment focus
  • Solar, Semiconductor, Information Technology
  • Series A, Series B, Private Equity
  • Australia, United States
Portfolio highlights
  • Heidi Health — Heidi Health is modernizing primary care with AI-powered technologies to improve care's quality and accessibility. its creators and engineers is to completely eradicate missed and sluggish diagnoses worldwide. They are committed to bridging the gap between the level of care that patients desire and the level of care that doctors can delivergiven their budget constraints. To create a platform where patients can quickly and easily get the treatment they require and to give every clinician the resources they need to deliver care that is secure, efficient,
  • SafetyCulture — SafetyCulture is the operational heartbeat of working teams around the world. Its mobile-first operations platform leverages the power of human observation to identify issues and opportunities for businesses to improve everyday. More than 28,000 organisations use its flagship products, iAuditor and EdApp, to perform checks, train staff, reportissues, automate tasks and communicate fluidly. SafetyCulture powers over 600 million checks per year, approximately 50,000 lessons per day and millions of corrective actions, giving leaders visibility and workers a voice, in driving safety, quality and efficiency improvements.
  • Generate Capital — Generate Capital is a finance company that builds, owns, and operates sustainable infrastructure to deliver affordable and reliable resource solutions. The company operates and finances assets in energy, mobility, and water resources.
Hostplus VC Fund · Melbourne, Victoria, Australia · 3 investments in the past 12 months
Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more
Investment focus
  • Software, Biotechnology, Financial Services
  • Series B, Series A, Series C
  • Australia, United Kingdom, United States
Portfolio highlights
  • Heidi Health — Heidi Health is modernizing primary care with AI-powered technologies to improve care's quality and accessibility. its creators and engineers is to completely eradicate missed and sluggish diagnoses worldwide. They are committed to bridging the gap between the level of care that patients desire and the level of care that doctors can delivergiven their budget constraints. To create a platform where patients can quickly and easily get the treatment they require and to give every clinician the resources they need to deliver care that is secure, efficient,
  • Hysata — Hysata is a developer of hydrogen electrolyzer designed to accelerate the world's shift away from fossil fuels to green hydrogen
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Square Peg Capital VC Fund · Melbourne, Victoria, Australia · 10 investments in the past 12 months
Square Peg is a global investment firm on a mission to empower exceptional founders. With investing teams in Sydney, Melbourne, Tel Aviv, and Singapore, Square Peg invests in emerging technology companies across the internet economy.
Show more
Investment focus
  • Software, SaaS, Financial Services
  • Seed, Series A, Series B
  • Australia, United States, Israel
Portfolio highlights
  • Neara — Predictive modeling software for proactive network governance. Quantify and prove network needs in any scenario. Run precise analyses in hours and days instead of months or years in the field.
  • Qodo — Qodo (formerly CodiumAI) offers quality-first AI tools for developers to write, test, and review code directly within their IDE and Git.
  • Lorikeet — Lorikeet provides AI customer support. Lorikeet offer its customers responsive, personalized, and effective support as table stakes.
HTC VC Fund · Taoyüan, T'ai-wan, Taiwan
HTC Corp is engaged in the design, development, and manufacture of smartphones and tablets in Taiwan.The company offers PDA phones and smartphones for mobile operators and distributors in Europe, the United States, and Asia. These machines are available as HTC devices and as products individually customized for operators and device partners.The company provides its own HTC self-branded products as well as supports operator-branded products and original equipment manufacturer (OEM) partners. It owns Dopod as a subsidiary company and is a member of the Open Handset Alliance.The company’s products are sold under various brand names such as HTC, Dopod, and Qtek and are often rebranded by major telecommunication carriers. Its products also include pocket PC phones (PDA Phone), ultra mobile phones, HTC kovsky (Sony Ericsson XPERIA X1), and HTC dream (T-mobile G1).HTC Corp was founded by Cher Wang and Peter Chou in 1997. It is headquartered in New Taipei City, Taiwan.
Show more
Investment focus
  • Virtual Reality, Software, Augmented Reality
  • Series A, Seed, Funding Round
  • United States, Taiwan, China
Portfolio highlights
  • Hexa — Elevate your eCommerce experience with a 3D tech-stack that lets you create, manage, analyze, and distribute your 3D commerce assets.
  • Camsense — Camsense focuses on R&D and manufacturing of vision space positioning technology. It provides customers with highly precise sensors with its self-developed core algorithm and chips. Its products can be applied in consumer robots, industrial test, and surgeries.
  • Inworld AI — AI for Metaverse
AngelLoop VC Fund · Oakland, California, United States
Angeloop provides a social and business intelligence platform for Startups and Investors to leverage those networks to their full extent.
Show more
Investment focus
Portfolio highlights
  • Gelomics — Gelomics operates as a biotechnology company. Gelomics provides 3D cell culture technologies.
Medibank VC Fund · Docklands, Victoria, Australia
Get Award Winning cover. Voted Outstanding Value Health Insurance for 16 Consecutive Years. Choose from flexible cover options & join online today.
Show more
Investment focus
  • Medical, Health Care, Information and Communications Technology (ICT)
  • Corporate Round
  • Australia
Portfolio highlights
  • Medinet — Streamline your medical practice and improve employee wellness with Medinet's comprehensive practice management and corporate health services.
CP Ventures VC Fund · Sydney, New South Wales, Australia
CP Ventures is a VC fund that invests internationally in early stage, highly scalable, breakthrough technology companies driven by the 4IR
Show more
Investment focus
  • Software, Artificial Intelligence, Machine Learning
  • Seed, Pre-Seed, Series A
  • Australia, United States, India
Portfolio highlights
  • Anility — Embed financial health insights within your application using our world leading API service
  • Ahura AI — Ahura AI, an EdTech startup using artificial intelligence to create personalized learning tools that replicate a 1-to-1 learning experience
  • Ensuredit — ENSUREDIT enables and empowers end customers and Insurance Intermediaries with AI-based product platforms for transformational customer experience.
Thorney Investment VC Fund · Melbourne, Victoria, Australia
Thorney Opportunities Ltd is an investment company. The Company's principal activity is making investments in listed securities. The Company is focused on producing absolute returns for shareholders over the medium to long-term. Its primary focus is on the selection of investments, which enable it to be a catalyst towards unlocking the valuein the companies that it identifies. The Company's investment manager is Thorney Management Services Pty Ltd.
Show more
Investment focus
  • Software, Internet, Artificial Intelligence
  • Series A, Funding Round, Series B
  • Australia, United States, Israel
Portfolio highlights
  • Willed — Write your Will and Powers of Attorney online with Willed. Get help with Probate, arrange a funeral service, direct cremation or prepaid funeral plan.
  • Earnity — Your new favorite crypto community. Build a portfolio in minutes, copy and share collections, and discuss the latest tokens and research. Create your profile now.
  • Buildxact — Buildxact is an easy to use construction management and estimating software designed for small builders and contractors. Sign up for your 14-day free trial.
BetterLabs Ventures VC Fund · Australia, Isabela, Philippines
BetterLabs is an early-stage venture capital fund and venture studio based in Perth, Australia. Backed by RAC the fund invests in technology and opportunities that impact next-generation insurance, clean technology, mobility, work and money. The studio creates ventures to solve challenges in these domains and we also invest in them.
Show more
Investment focus
  • Education, E-Commerce, Artificial Intelligence
  • Seed, Grant, Pre-Seed
  • Australia, United States
Portfolio highlights
  • upcover — upcover is Australia's award winning Online business insurance provider for All type of business owners, startups, consultants, freelancers and gig economy workers in Australia. Get a quote online today.
  • WeMoney — WeMoney is focused on obtaining an Open Banking license so that the Fintech firm can gain access to customer banking data, which may be used to improve the quality of services offered to them.WeMoney’s platform lets users keep track of their pending utility bills and other recurring payments. The platform also aims to help customers with managingtheir savings and monitoring their monthly income. Joveski revealed that his company is also developing features that will use behavioral science and AI to help users make better or more informed financial decisions.
  • Loopit — Loopit is the complete end-to-end software & professional services platform solution for car subscription to boost dealership & profitability.
SFC Capital VC Fund · London, England, United Kingdom · 37 investments in the past 12 months
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Pre-Seed, Seed, Funding Round
  • United Kingdom, United States, Canada
Portfolio highlights
  • Recfindr — Recfindr is a startup building a recruitment management system.
  • Implement AI — Implement AI provides managed AI agent solutions and teams of virtual workers via its AI Agent Platform, offering SMEs cost-effective, enterprise-grade solutions to amplify human potential, optimise productivity, and drive growth.
  • CareLoop Health — CareLoop, an innovation emerging from the University of Manchester, furnishes patients with digital support resources while simultaneously providing healthcare professionals with the means to monitor and track patient symptoms.
Lilly Ventures VC Fund · Indianapolis, Indiana, United States
Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under managementand focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series C, Series B, Series A
  • United States, Israel, Australia
Portfolio highlights
  • IpiNovyx Bio — Orange Grove Bio partners with leading research universities to advance preclinical biotech programs in the oncology space. The company leverages its venture capital and drug development expertise to help patients and build biotech ecosystems.
  • Evox Therapeutics — Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of therapeutics. Backed by leading Life Sciences Venture Capital groups and supported by a comprehensive intellectualproperty portfolio, Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of various severe diseases with limited options for patients and their families.Evox has created substantial proprietary technology to modify exosomes using various molecular engineering, drug loading, and targeting strategies to facilitate targeted drug delivery to organs of interest, including the brain and the central nervous system. Exosome-based drugs have the potential to address some of the limitations of protein, antibody and nucleic acid-based therapies by enabling delivery to cells and tissues that are currently out of reach using other drug delivery technologies. Evox is leading the development within this emerging therapeutic space.
  • Kymera Therapeutics — Advancing targeted protein degradation to deliver next-generation medicines
SG Hiscock VC Fund
SG Hiscock
Show more
Investment focus
  • Software, Legal, Medical
  • Series A, Funding Round
  • Australia
Portfolio highlights
  • Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
  • Immediation — Sophisticated video conferencing for dispute resolution and legal practice. Built by Lawyers, for Lawyers. Start your free 14-day trial today.
  • Marketplacer — Marketplacer is a marketplace platform and dropshipping solution that allows enterprise companies to scale and grow in today's evolving e-commerce environment.
CSIRO VC Fund · Campbell, Victoria, Australia
As Australia's national science agency and innovation catalyst, we solve the greatest challenges through innovative science and technology.
Show more
Investment focus
  • Software, Agriculture, Health Care
  • Series A, Funding Round
  • Australia, United States
Portfolio highlights
  • Coviu — Video chat, secure messaging, appointment booking, prescription delivery, in-app assessments, in-call tools. Made for practitioners, clinics and hospitals.
  • FutureFeed — Established by CSIRO, FutureFeed holds global IP for the use of Asparagopsis seaweed as a livestock feed ingredient, shown to lower ruminant methane emissions by 80% or more, while producing feed efficiencies.
  • Digital Agriculture Services — SaaS for financial services. Data, imagery, software and CRM integrations decision-makers need to lend, insure, invest, sell and serve customers.
VU Venture Partners VC Fund · San Francisco, California, United States · 5 investments in the past 12 months
A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech
Show more
Investment focus
  • Software, Health Care, Machine Learning
  • Seed, Funding Round, Series A
  • United States, Colombia, India
Portfolio highlights
  • Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
  • MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
  • Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
Jelix Ventures VC Fund · Sydney, New South Wales, Australia · 4 investments in the past 12 months
Jelix is an early-stage venture capital firm backing daring founders in Australia and New Zealand.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Funding Round
  • Australia, New Zealand, United States
Portfolio highlights
  • Fugu — Cheap green carbon at scale for the dawn of the e-fuel age
  • Fugu Carbon — Fugu Carbon is a machinery manufacturing company that helps in carbon dioxide removal (CDR) technology from air.
  • Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
Tyson & Blake VC Fund · London, England, United Kingdom
Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.
Show more
Investment focus
  • Medical, Facial Recognition, Artificial Intelligence
  • Seed, Funding Round
  • Australia
Portfolio highlights
  • Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
Pollenizer VC Fund · Surry Hills, New South Wales, Australia
Pollenizer is a co-founder of start-up web businesses in Australia. They partner with strong founders and take equity stakes at a concept stage on consumer and SaaS businesses. The skill sets cover technology, marketing and capital raising. They also occasionally make seed investments. Their businesses include;* * ** * * * * * * * * * Their team includes;* Phil Morle, ex-CTO of Kazaa, Omnidrive.* Mick Liubinskas, ex-CMO of Kazaa, Tangler, ZaprThey are also investors and partners with
Show more
Investment focus
  • E-Commerce, B2B, Marketplace
  • Seed, Angel, Funding Round
  • Australia
Portfolio highlights
  • LawPath — Create legal documents, manage compliance and connect with lawyers on demand. Less stress, more time and better business. Sign up for free.
  • CohortIQ — cohortiQ Home Page
  • HiveXchange — Designed and built in Australia for the fresh produce industry. Find opportunities, create private offers, make product requests, get notified of deals in real time. Trade easy.
Black Nova Venture Capital VC Fund · Surry Hills, New South Wales, Australia
Championing the next generation of B2B technology startups.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Pre-Seed, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • 8seats — 8seats offers secure, effortless messaging! Boost productivity with real-time chat, team collaboration, and tools designed for businesses of any size. Get started for free!
  • Nullify — Nullify performs product security tasks alongside your developers.
  • Altai — Altai is a bespoke casting platform which offers unparalleled collaboration between Artists, Agents, Casting Directors and Clients.
Ramsay Health Care VC Fund · Sydney, New South Wales, Australia
Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A
  • Australia
Portfolio highlights
  • Harrison.ai — Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools thatintegrate into existing clinical workflows which ultimately lead to improved patient outcomes.Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images.Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients.Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.
Queensland Investment Corporation VC Fund · Brisbane, Queensland, Australia · 2 investments in the past 12 months
Queensland Investment Corporation is an investment company.
Show more
Investment focus
  • Information Technology, Software, Financial Services
  • Seed, Series A, Funding Round
  • Australia, United States
Portfolio highlights
  • Gelomics — Gelomics operates as a biotechnology company. Gelomics provides 3D cell culture technologies.
  • Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
  • Renewa — Renewa is a top renewable energy land & infrastructure investor that buys land, ground leases, & royalties to help landowners attain financial security.
Breakthrough Victoria VC Fund · Melbourne, Victoria, Australia · 14 investments in the past 12 months
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more
Investment focus
  • Manufacturing, Health Care, Software
  • Funding Round, Series A, Seed
  • Australia, United States, Philippines
Portfolio highlights
  • Umps Health — Umps offers a 24/7 personal alarm that helps you live independently with peace of mind. Easy to use, always connected.
  • Conflux Technology — Conflux Technology is a new generation of heat exchangers made by metal additive manufacturing (3D printing).
  • Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
Skip Capital VC Fund · Sydney, New South Wales, Australia · 8 investments in the past 12 months
Skip Capital is a private investment fund investing in technology and infrastructure
Show more
Investment focus
  • Software, Artificial Intelligence, SaaS
  • Series A, Seed, Series B
  • Australia, United States, Canada
Portfolio highlights
  • Askable — Askable offers a comprehensive research platform that facilitates access to certified researchers and verified participants globally. The platform streamlines the research process from recruitment to analysis, enabling teams to gather insights efficiently.
  • Visibuild — Visibuild is a construction software web & mobile platform providing real-time insights, workflows, defect tracking, ITPs inspections.
  • GROWL — Discover GROWL: the smart boxing bag blending cardio, strength, and gaming. Experience an immersive home boxing coach and step up your performance.
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
QIC BioVentures VC Fund · Brisbane, Queensland, Australia
QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A
  • Australia
Portfolio highlights
  • Verva Pharmaceuticals — Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined productportfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
  • Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Northpond Ventures VC Fund · Bethesda, Maryland, United States · 3 investments in the past 12 months
Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.
Show more
Investment focus
  • Biotechnology, Health Care, Life Science
  • Series A, Series B, Series C
  • United States, United Kingdom, Canada
Portfolio highlights
  • Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
  • VieCure — The VieCure platform is an Clinical Decision Support solution in Oncology that combines the power of artificial intelligence, codified clinical rules and pathways, precision oncology, telehealth, smartphone technology, and the EMR to transform cancer care.
  • Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
Watermark Funds Management VC Fund · Sydney, New South Wales, Australia
Watermark Funds Management. A specialist long/short investor offering attractive returns while hedging share market risks.
Show more
Investment focus
  • Medical, Software, Health Care
  • Series A
  • Australia
Portfolio highlights
  • Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Australia by industry